Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Integrin beta 3 Binding Protein (Beta3-Endonexin) (ITGB3BP) (N-Term) Peptide

ITGB3BP Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN978662
  • Target See all ITGB3BP products
    ITGB3BP (Integrin beta 3 Binding Protein (Beta3-Endonexin) (ITGB3BP))
    Protein Region
    N-Term
    Origin
    Human
    Source
    • 2
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-ITGB3BP antibody (Catalog #: ARP54999_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    ITGB3BP (Integrin beta 3 Binding Protein (Beta3-Endonexin) (ITGB3BP))
    Synonyms
    CENP-R Peptide, CENPR Peptide, HSU37139 Peptide, NRIF3 Peptide, TAP20 Peptide, 4930471O16Rik Peptide, AU022583 Peptide, integrin subunit beta 3 binding protein Peptide, integrin beta 3 binding protein (beta3-endonexin) Peptide, ITGB3BP Peptide, Itgb3bp Peptide
    Background
    ITGB3BP is a transcription coregulator that can have both coactivator and corepressor functions. Isoform 1, but not other isoforms, is involved in the coactivation of nuclear receptors for retinoid X (RXRs) and thyroid hormone (TRs) in a ligand-dependent fashion. ITGB3BP acts as a transcriptional corepressor via its interaction with the NFKB1 NF-kappa-B subunit, possibly by interfering with the transactivation domain of NFKB1. It induces apoptosis in breast cancer cells, but not in other cancer cells, via a caspase-2 mediated pathway that involves mitochondrial membrane permeabilization but does not require other caspases. ITGB3BP may also act as an inhibitor of cyclin A-associated kinase. ITGB3BP may be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex.

    Alias Symbols: CENP-R, CENPR, HSU37139, NRIF3, TAP20

    Protein Interaction Partner: MTA1,ARFIP2,CCNA2,COL4A3BP,DDX24,ESR1,ITGB3,ITGB3BP,ITGB5,MTA1,NFKB1,RECQL5,RXRA,ARFIP2,CCNA2,COL4A3BP,DDX24,ITGB3,ITGB3BP,ITGB5,NFKB1,RECQL5,RELA,RXRA,RXRG,THRA

    Protein Size: 177
    Molecular Weight
    20 kDa
    Gene ID
    23421
    NCBI Accession
    NM_014288, NP_055103
    UniProt
    Q13352
You are here:
Support